O

ONCOLOGIX (Private limited company)

BE 1027.890.093 Active ●Rue Alphonse De Witte 50, 1050 Ixelles

ONCOLOGIX is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 1027.890.093. It was founded on 19-09-2025. Its registered office is in Ixelles. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 29 776 and a profit of € 29 775. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk).

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 1027.890.093
VAT registered
Yes
Founded
19-09-2025
Latest accounts
2025
Employees
-
Region
Brussels-Capital
Establishments
1
Peppol e-invoicing
Registered
Registered office
Rue Alphonse De Witte 50, 1050 Ixelles
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles
58190 Autres activités d’édition, à l’exception de l’édition de logiciels
82300 Organisation de salons professionnels et congrès
85592 Formation professionnelle

Key figures of ONCOLOGIX

2025
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 29 775
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 29 776
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 53 513
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 37 479
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
-

Financial estimate

Financial health grade B, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Ixelles.

CompanyTown
S - CLINICA 1050 Ixelles
European Medical Solutions 1050 Ixelles
AZOR 1050 Ixelles
BELGIAN INSTITUTE OF HUMAN RESEARCH 1050 Ixelles
MULTIFACE 1050 Ixelles
MK ENGINEERING 1050 Ixelles
BESINS HEALTHCARE BENELUX 1050 Ixelles
WYETH LEDERLE VACCINES 1050 Ixelles
Looking for more information about ONCOLOGIX?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is ONCOLOGIX still active? Yes. The Crossroads Bank for Enterprises lists ONCOLOGIX as active.

What is the VAT number of ONCOLOGIX? The VAT number of ONCOLOGIX is BE 1027.890.093.

When was ONCOLOGIX founded? ONCOLOGIX was founded on 19-09-2025.

What is the address of ONCOLOGIX? The current registered office of ONCOLOGIX is Rue Alphonse De Witte 50, 1050 Ixelles.

When did ONCOLOGIX last file annual accounts? The latest annual accounts of ONCOLOGIX were filed on 28-08-2026.

Is ONCOLOGIX financially healthy? Addrly gives ONCOLOGIX a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is ONCOLOGIX profitable? The annual accounts of ONCOLOGIX for 2025 show a profit of € 29 775.

What is the equity of ONCOLOGIX? The equity of ONCOLOGIX was € 29 776 at the close of the 2025 financial year.

Who are the directors of ONCOLOGIX? The annual accounts of ONCOLOGIX record 1 mandate. The name, role and dates are visible with a free account.

Can ONCOLOGIX receive Peppol e-invoices? Yes. ONCOLOGIX is registered on the Peppol network and can receive structured electronic invoices.

What does ONCOLOGIX do? The main activity of ONCOLOGIX is: Scientific research and development.

Sources

How Addrly builds and refreshes this data